Bosch: Critial Factors for Connected Medical Devices of the Future
Bosch Conversations: Critical Factors for Connected Medical Devices of the Future, will feature a select group of healthcare executives and innovators who will gather to network and learn firsthand about critical factors needed to ensure success for connected medical devices of the future. This Bosch Conversations Event is brought to you by Bosch and HealthFactors, and co-sponsored by MASSMedic, Halloran Consulting Group, and Health Advances.
Clinical operations breakfast: Science 37 at Sanofi
One of the biggest challenges in clinical research is getting and keeping patients engaged. It is estimated that about 70% of trial delays are caused by slow patient recruitment. Science 37 has changed the paradigm by bringing the trial to the patient.
Clinical operations breakfast: eTMF at Alnylam
Every life science company faces two basic dilemmas as they move through clinical development creating the story of the program for future scrutiny: 1) to eTMF or not to eTMF, and 2) to outsource oversight for the Trial Master File to a CRO or spend internal resources on management?
Behind closed doors at CORE 2017
The happenings at Halloran’s Clinical Operations Retreat for Executives (better known as CORE) have long been kept under wraps. This year marked the 11th retreat, and we wanted to give everyone a peek inside.
Halloran Announces Participation in September Industry Events
Halloran is pleased to announce that we will be participating in three industry events in the month of September. Thought leaders from Halloran will be speaking on panels, presenting on key trends and meeting with peers to discuss opportunities and challenges facing pharma, biotech, and life sciences.
Drug Development and Transactional Deal Landscape for Neurodegenerative Disorders
NDDs impact a significant number of the global population and are the leading cause of disability and morbidity in the US. There is a long history of failed attempts to develop effective therapies, and currently, there are no treatments that can prevent, slow down or cure NDDs.
Selecting Preferred Vendors: Best Practices for Different Phases
Join us on July 13 at Jounce Therapeutics as we discuss best practices for different phases when selecting preferred vendors.